Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Swanbio Therapeutics Limited

United Kingdom 2nd Floor, 8 Bloomsbury Street, WC1B 3SR, United Kingdom

About the sponsor

Swanbio Therapeutics Limited focuses on adrenomyeloneuropathy, a rare genetic disorder affecting the nervous system and spinal cord, with clinical interest centered on disease-modifying treatment for adults living with this condition.

  • Adrenomyeloneuropathy
  • ABCD1-related disease
  • Rare inherited neurologic disease

The sponsor’s research activity is directed toward therapeutic approaches that address the underlying neurologic and metabolic consequences of this inherited condition.

About Specializations

Swanbio Therapeutics Limited runs clinical trials in conditions such as Adrenoleukodystrophy, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Adrenoleukodystrophy

Not recruiting
InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Adeno-Associated Viral Vector Serotype 9 Containing The Human Habcd1 Gene
  • Sponsor:Swanbio Therapeutics Limited

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.